34 results match your criteria: "Henan University College of Medicine[Affiliation]"

Article Synopsis
  • CD24 is a heavily glycosylated protein found in immune cells and cancer cells, serving as a crucial cancer biomarker and interacting with Siglec-10 to modulate inflammation in diseases.
  • The binding of CD24 to Siglec-10 helps inhibit inflammation linked to SHP-1/2 phosphatases and reduces macrophage activity, which can impact the immune response to cancer.
  • The study highlights recent advances in CD24/Siglec-10-targeted immunotherapy, suggesting it as a promising approach in cancer treatment and discussing potential future research directions based on recent trial outcomes.
View Article and Find Full Text PDF

As a newly identified checkpoint, T cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif (ITIM) domain (TIGIT) is highly expressed on CD4 T cells, CD8 T cells, natural killer (NK) cells, regulatory T cells (Tregs), and tumor-infiltrating lymphocytes (TILs). TIGIT has been associated with NK cell exhaustion in vivo and in individuals with various cancers. It not only modulates NK cell survival but also mediates T cell exhaustion.

View Article and Find Full Text PDF

Thymidylate kinase (TMPK) of monkeypox virus (MPXV) has emerged as a promising target for potential therapeutics due to its significant role in pyrimidine metabolism. While smallpox drugs are advised for treating monkeypox, the European Medicine Agency has sanctioned Tecovirimat due to its potent nanomolar activity. Nonetheless, there is a need for monkeypox-specific therapeutic options.

View Article and Find Full Text PDF

Editorial: Evolution, pathogenesis, host interactions and therapeutic strategies against monkeypox virus.

Front Cell Infect Microbiol

October 2023

Henan International Joint Laboratory of Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, Henan, China.

View Article and Find Full Text PDF
Article Synopsis
  • Recent research highlights bispecific antibodies (BsAbs) as an innovative immunotherapy, with multiple forms actively being developed.
  • In 2022, four BsAbs (tebentafusp, faricimab, mosunetuzumab, and teclistamab) received clinical approval, and new ones like odronextamab and talquetamab are currently undergoing trials.
  • Data from the 28th European Hematology Association annual meeting suggest that BsAbs show promising response rates in difficult-to-treat blood cancers, particularly in patients with relapsed or refractory conditions.
View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on IMM47, an anti-CD24 monoclonal antibody, and its effectiveness in targeting tumors through several laboratory techniques, including biolayer interferometry and flow cytometry.
  • IMM47 shows a strong affinity for granulocytes and effectively disrupts the interaction between CD24 and Siglec-10, enhancing its anti-tumor activity against REH cells in mouse models.
  • The antibody also demonstrates significant therapeutic benefits when used in combination with other treatments like Tislelizumab and Keytruda, maintaining a safe profile while promoting immune responses against tumors.
View Article and Find Full Text PDF

Toll-like receptors (TLRs) are a large family of proteins that are expressed in immune cells and various tumor cells. TLR7/8 are located in the intracellular endosomes, participate in tumor immune surveillance and play different roles in tumor growth. Activation of TLRs 7 and 8 triggers induction of a Th1 type innate immune response in the highly sophisticated process of innate immunity signaling with the recent research advances involving the small molecule activation of TLR 7 and 8.

View Article and Find Full Text PDF

We aimed to validate and prove the novel risk score models of acute myeloid leukemia (AML)-specific disease risk group (AML-DRG) and AML-Hematopoietic Cell Transplant-composite risk (AML-HCT-CR) in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (AHCT). Among the 172 AML patients analysed, 48.3% (n = 83) were females.

View Article and Find Full Text PDF

The physiological function and prognostic significance of C-type lectin domain family 12 member A (CLEC12A) in acute myeloid leukemia (AML) patients are unclear. CLEC12A transcriptional expression in a variety of tumors from several public databases was collected and compared. We found that CLEC12A was highly expressed in AML cell lines and in tissues from AML patients and a higher CLEC12A expression in leukemia stem cells.

View Article and Find Full Text PDF

Biology of PEST-Containing Nuclear Protein: A Potential Molecular Target for Cancer Research.

Front Oncol

February 2022

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, China.

PEST-containing nuclear protein (PCNP), a novel nuclear protein, is involved in vital cellular processes like cell proliferation and mediates tumorigenesis. PCNP is a short-living, small nuclear protein of only 178 amino acids with two remarkable PEST sequences that are rich in proline (P), glutamic acid (E), serine (S), and threonine (T). The current understanding of PCNP reveals that PCNP has the ability to interact with cell cycle regulatory proteins; tumor suppressors (p53 and pRB), and promoters (cyclin E and cyclin D) to determine the fate of tissues to facilitate the process of either apoptosis or cell proliferation.

View Article and Find Full Text PDF

Dendritic cell (DC) vaccines induce specific immune responses that can selectively eliminate target cells. In recent years, many studies have been conducted to explore DC vaccination in the treatment of hematological malignancies, including acute myeloid leukemia and myelodysplastic syndromes, as well as other nonleukemia malignancies. There are at least two different strategies that use DCs to promote antitumor immunity: in situ vaccination and canonical vaccination.

View Article and Find Full Text PDF

Much progress has been made in targeting CD47 for cancer immunotherapy in solid tumors (ST) and hematological malignancies. We summarized the CD47-related clinical research and analyzed the research trend both in the USA and in China. As of August 28, 2021, there are a total 23 related therapeutic agents with 46 clinical trials in the NCT registry platform.

View Article and Find Full Text PDF

Emerging evidence has demonstrated that N -methyladenosine (m A) and long noncoding RNAs (lncRNAs) are both crucial regulators in gastric cancer (GC) tumorigenesis. However, the interaction of m A and lncRNAs in GC progression are still unclear. Here, our team discovered that lncRNA LINC00958 expression up-regulated in GC tissue and cells.

View Article and Find Full Text PDF

Better Reporting and Awareness Campaigns Needed for Breast Cancer in Pakistani Women.

Cancer Manag Res

March 2021

Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, Henan, 475004, People's Republic of China.

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer deaths in women globally. In 2018, 2.1 million new cases were reported, with 627,000 deaths.

View Article and Find Full Text PDF

Personal-Care Cosmetic Practices in Pakistan: Current Perspectives and Management.

Clin Cosmet Investig Dermatol

January 2021

Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Henan 475001, People's Republic of China.

To look superior and acceptable in society, people from all over the world use various types of cosmetic products to enhance or alter their facial appearance and body texture. In recent times, an exponential surge in cosmetic use has been observed in Pakistan, and hence spending money on personal-care products is high. However, there are many reported facts about high loads of lead, mercury, copper, and others hazardous and cancerous elements in local Pakistani cosmetic brands.

View Article and Find Full Text PDF

Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Melanoma.

Front Oncol

October 2020

Kaifeng Key Laboratory for Infectious Diseases and Biosafety, Henan International Joint Laboratory of Nuclear Protein Regulation, Henan School of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.

Melanoma is the deadliest skin tumor and is prone to distant metastases. The incidence of melanoma has increased rapidly in the past few decades, and current trends indicate that this growth is continuing. This study was aimed to explore the molecular mechanisms of melanoma pathogenesis and discover underlying pathways and genes associated with melanoma.

View Article and Find Full Text PDF

Multifaceted behavior of PEST sequence enriched nuclear proteins in cancer biology and role in gene therapy.

J Cell Physiol

March 2021

Henan International Joint Laboratory for Nuclear Protein Regulation & Kaifeng Key Laboratory of Infectious Diseases and Bio-safety, School of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, Henan, China.

The amino acid sequence enriched with proline (P), glutamic acid (E), serine (S), and threonine (T) (PEST) is a signal-transducing agent providing unique features to its substrate nuclear proteins (PEST-NPs). The PEST motif is responsible for particular posttranslational modifications (PTMs). These PTMs impart distinct properties to PEST-NPs that are responsible for their activation/inhibition, intracellular localization, and stability/degradation.

View Article and Find Full Text PDF

PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition.

J Cell Mol Med

July 2020

Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, China.

Ever reports showed that PCNP is associated with human cancers including neuroblastoma and lung cancer. However, the role and underlying molecular mechanism of PCNP in ovarian cancer have not been plenty elucidated. Herein, we first investigated the expression of PCNP in ovarian cancer tissues and cells, the effects of PCNP in ovarian cancer proliferation, apoptosis, migration and invasion, and determined the molecular mechanism of PCNP in ovarian cancer progression.

View Article and Find Full Text PDF

Background: Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1/S1P pathway is implicated in the progression of chronic kidney disease. However, the role of SphK1/S1P pathway in renal injury in hypertension has not been reported.

View Article and Find Full Text PDF
Article Synopsis
  • * A 26-year-old woman with CCTGA experienced severe symptoms, including palpitations and syncope, and was found to have high-degree atrioventricular block and bradycardic ventricular fibrillation during her hospital stay.
  • * After evaluating her condition and options, she opted for dual-chamber pacemaker implantation, leading to an uneventful recovery and active lifestyle in follow-ups, highlighting the importance of personalized treatment decisions in managing complex heart conditions.
View Article and Find Full Text PDF

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells.

Cell Death Dis

October 2019

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.

MET overactivation is one of the crucial reasons for tyrosine kinase inhibitor (TKI) resistance, but the mechanisms are not wholly clear. Here, COX2, TOPK, and MET expression were examined in EGFR-activating mutated NSCLC by immunohistochemical (IHC) analysis. The relationship between COX2, TOPK, and MET was explored in vitro and ex vivo.

View Article and Find Full Text PDF

Taking a holistic view of PEST-containing nuclear protein (PCNP) in cancer biology.

Cancer Med

October 2019

Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, China.

Polypeptide sequences enriched with proline (P), glutamic acid (E), aspartic acid (D) and serine (S)/ threonine (T) (PEST) have been reported to be the most abundant and frequently distributed at the cellular level. There is growing evidence that PEST sequences act as proteolytic recognition signals for degradation of residual proteins which is critical for activation or deactivation of regulatory proteins involved in cellular signaling pathways of cell growth, differentiation, stress responses and physiological death. A PEST containing nuclear protein (PCNP) was demonstrated as a tumor suppressor in a neuroblastoma cancer model and tumor promoter in lung adenocarcinoma cancer model.

View Article and Find Full Text PDF

Background: Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in various diseases. S1P also plays significant roles in the differentiation of fibroblasts into myofibroblasts, being implicated in fibrotic diseases. S1P is produced by the phosphorylation of sphingosine catalyzed by sphingosine kinases (SphK1 and SphK2).

View Article and Find Full Text PDF

A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways.

Cancer Lett

July 2019

Institute for Innovative Drug Design and Evaluation, School of Pharmacy, Henan University, Kaifeng, Henan, 475004, China; Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, Henan, 475004, China. Electronic address:

Breast cancer is one of the most frequent cancers among women worldwide. Hyaluronic acid (HA) is one of the best biopolymers in terms of safety issues and has been widely used in drug delivery and tissue engineering. 5-(4-hydroxyphenyl)-3H-1,2-dithiol-3-thione (ADT-OH) is a commonly used HS donor.

View Article and Find Full Text PDF